Project Details
| Short title | SGNDV-001 |
|---|---|
| Acronym | SGNDV-001 |
| Status | Active |
| Effective start/end date | 21/09/23 → 21/09/28 |
CTU: A study of Disitamab Vedotin with pembrolizumab vs chemotherapy in HER2-Expressing Urothelial Carcinoma
- Zhang, Alison (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Contacos, Christine (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
Project: Research